↓ Skip to main content

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Overview of attention for article published in Trials, May 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

news
1 news outlet
twitter
2 tweeters
reddit
1 Redditor

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
277 Mendeley
Title
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
Published in
Trials, May 2020
DOI 10.1186/s13063-020-04352-9
Pubmed ID
Authors

Yeming Wang, Fei Zhou, Dingyu Zhang, Jianping Zhao, Ronghui Du, Yi Hu, Zhenshun Cheng, Ling Gao, Yang Jin, Guangwei Luo, Shouzhi Fu, Qiaofa Lu, Guanhua Du, Ke Wang, Yang Lu, Guohui Fan, Yi Zhang, Ying Liu, Shunan Ruan, Wen Liu, Thomas Jaki, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 277 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 277 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 43 16%
Student > Bachelor 40 14%
Researcher 23 8%
Other 18 6%
Student > Ph. D. Student 16 6%
Other 47 17%
Unknown 90 32%
Readers by discipline Count As %
Medicine and Dentistry 72 26%
Nursing and Health Professions 21 8%
Biochemistry, Genetics and Molecular Biology 16 6%
Pharmacology, Toxicology and Pharmaceutical Science 16 6%
Agricultural and Biological Sciences 7 3%
Other 46 17%
Unknown 99 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2020.
All research outputs
#2,018,479
of 18,041,417 outputs
Outputs from Trials
#732
of 4,731 outputs
Outputs of similar age
#53,947
of 296,264 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 18,041,417 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,731 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 296,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them